Skip to main content
. 2013 Oct 10;8(10):e76958. doi: 10.1371/journal.pone.0076958

Figure 4. Kaplan-Meier analysis of the overall survival regarding CRP kinetics.

Figure 4

Kaplan-Meier analysis of overall survival of non-elevated (CRP < 3.4 mg/L and never elevated during treatment), elevated (CRP < 3.4 mg/L and elevated at least one time during treatment), normalized (CRP ≥ 3.4 mg/L and normalized at least one time during treatment) and non-normalized (CRP ≥ 3.4 mg/L and never normalized during treatment) groups patients with metastasis nasopharyngeal carcinoma (P < 0.0001).